Testing HS-20118 in healthy adults and psoriasis patients
Part of Skin clinical trials.
This study tests a new medicine called HS-20118 in two parts: one in healthy adults to see how the body handles a single dose, and another in people with chronic plaque psoriasis to see how it works over multiple doses. It helps find a safe dose and shows whether it might reduce psoriasis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 (for the single-dose study) or between 18 and 65 (for the multiple-dose study).
- Your weight is within the allowed range (men: at least 50 kg, women: at least 45 kg, and up to 110 kg).
- You are either a healthy volunteer or have had plaque psoriasis for at least 6 months.
- You do not have a history of serious infections, drug allergies, or recent drug abuse.
- Your overall health (physical exam, lab tests, heart test, and X-rays) is normal or has no concerning findings.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication (HS-20118) for safety and how it works in the body. It is for healthy volunteers or people with chronic plaque psoriasis, and will help see if the drug is safe and how it behaves with or without food.
This study tests an investigational oral medication called HS-10374 for moderate to severe plaque psoriasis. It aims to see how well it clears skin and prevents flares compared to a placebo, and if it is safe for long-term use.
This trial tests an oral medication called HS-10374 for people with mild to moderate plaque psoriasis who haven't gotten enough relief from topical treatments. The study will check if the drug is safe and effective at clearing psoriasis patches.
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
This trial tests a new medication called HB0017 for moderate to severe plaque psoriasis. It aims to see if it is safe and effective in reducing skin symptoms and improving quality of life.
This trial tests a new medication called HSK44459 for people with moderate to severe plaque psoriasis who need systemic therapy (medicine that works throughout the body). The goal is to see if it is safe and effective.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.